A comprehensive next-generation sequencing (NGS) assay for translational and early clinical research

The Oncomine Comprehensive Assay v3 is a multi-biomarker NGS assay that covers 161 of the most relevant cancer genes, based on the Oncomine Knowledgebase and from collaborations with leading cancer research institutions and pharmaceutical companies. The low sample input requirement enables the analysis of even small and challenging formalin-fixed paraffin-embedded (FFPE) samples.